Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Reduction in heart failure outcomes with SGLT2...
Journal article

Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status

Authors

Gerstein HC; Sattar N

Journal

The Lancet Diabetes & Endocrinology, Vol. 10, No. 12, pp. 831–832

Publisher

Elsevier

Publication Date

December 2022

DOI

10.1016/s2213-8587(22)00313-8

ISSN

2213-8587

Associated Experts

Hertzel Chaim Gerstein

Professor, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

3205 Medical biochemistry and metabolomics32 Biomedical and Clinical Sciences3202 Clinical sciences

Medical Subject Headings (MeSH)

HumansSodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsHeart Failure
View published work (Non-McMaster Users)
View published work (McMaster Users)